Microbial Natural Products with Antiviral Activities, Including Anti-SARS-CoV-2: A Review

Andri Frediansyah; Fajar Sofyantoro; Saad Alhumaid; Abbas Al Mutair; Hawra AlBayat; Hayyan I. Altaweil; Hani M. Al-Afghani; Abdullah A. AlRamadhan; Mariam R. AlGhazal; Safaa A. Turkistani; Abdulmonem A. Abuzaid; Ali A. Rabaan

doi:10.3390/molecules27134305

journal article Open Access Jul 05, 2022

Microbial Natural Products with Antiviral Activities, Including Anti-SARS-CoV-2: A Review

Andri Frediansyah

Fajar Sofyantoro

Saad Alhumaid

Abbas Al Mutair

Hawra AlBayat Hayyan I. Altaweil Hani M. Al-Afghani Abdullah A. AlRamadhan Mariam R. AlGhazal Safaa A. Turkistani

Abdulmonem A. Abuzaid Ali A. Rabaan

Molecules Vol. 27 No. 13 pp. 4305 · MDPI AG

View at Publisher Save 10.3390/molecules27134305

Abstract

The SARS-CoV-2 virus, which caused the COVID-19 infection, was discovered two and a half years ago. It caused a global pandemic, resulting in millions of deaths and substantial damage to the worldwide economy. Currently, only a few vaccines and antiviral drugs are available to combat SARS-CoV-2. However, there has been an increase in virus-related research, including exploring new drugs and their repurposing. Since discovering penicillin, natural products, particularly those derived from microbes, have been viewed as an abundant source of lead compounds for drug discovery. These compounds treat bacterial, fungal, parasitic, and viral infections. This review incorporates evidence from the available research publications on isolated and identified natural products derived from microbes with anti-hepatitis, anti-herpes simplex, anti-HIV, anti-influenza, anti-respiratory syncytial virus, and anti-SARS-CoV-2 properties. About 131 compounds with in vitro antiviral activity and 1 compound with both in vitro and in vivo activity have been isolated from microorganisms, and the mechanism of action for some of these compounds has been described. Recent reports have shown that natural products produced by the microbes, such as aurasperone A, neochinulin A and B, and aspulvinone D, M, and R, have potent in vitro anti-SARS-CoV-2 activity, targeting the main protease (Mpro). In the near and distant future, these molecules could be used to develop antiviral drugs for treating infections and preventing the spread of disease.

Topics

No keywords indexed for this article. Browse by subject →

References

202

[1]

Crowley "New hepatitis C virus infection, re-infection and associated risk behaviour in male Irish prisoners: A cohort study, 2019" Arch. Public Health (2021) 10.1186/s13690-021-00623-2

[2]

Does urbanization make emergence of zoonosis more likely? Evidence, myths and gaps

Sohel Ahmed, Julio D Dávila, Adriana Allen et al.

Environment and Urbanization 2019 10.1177/0956247819866124

[3]

Spinella "Simulation of the impact of people mobility, vaccination rate, and virus variants on the evolution of COVID-19 outbreak in Italy" Sci. Rep. (2021) 10.1038/s41598-021-02546-y

[4]

Delaugerre "Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): A non-inferiority, randomised, controlled trial" Lancet Infect. Dis. (2022) 10.1016/s1473-3099(21)00673-3

[5]

Impact of global warming on viral diseases: what is the evidence?

Roland Zell, Andi Krumbholz, Peter Wutzler

Current Opinion in Biotechnology 2008 10.1016/j.copbio.2008.10.009

[6]

Yan "Engineering. Trends in global warming and evolution of polymerase basic protein 2 family from influenza A virus" J. Biomed. Sci. (2009)

[7]

Frediansyah "Antivirals for COVID-19: A critical review" Clin. Epidemiol. Glob. Health (2021) 10.1016/j.cegh.2020.07.006

[8]

Smith "Globalization of human infectious disease" Ecology (2007) 10.1890/06-1052.1

[9]

Chaitanya, K. (2019). Structure and Organization of Virus Genomes. Genome and Genomics, Springer. 10.1007/978-981-15-0702-1_1

[10]

Worldometers (2022, May 21). COVID-19 Coronavirus Pandemic. Available online: https://www.worldometers.info/coronavirus/.

[11]

Bacterial competition: surviving and thriving in the microbial jungle

Michael E. Hibbing, Clay Fuqua, Matthew R. Parsek et al.

Nature Reviews Microbiology 2010 10.1038/nrmicro2259

[12]

Zhang "Exploring novel bioactive compounds from marine microbes" Curr. Opin. Microbiol. (2005) 10.1016/j.mib.2005.04.008

[13]

Haruna "Recent advances in the chemistry of bioactive compounds from plants and soil microbes: A review" Chem. Afr. (2021) 10.1007/s42250-020-00213-9

[14]

Firn "Natural products—A simple model to explain chemical diversity" Nat. Prod. Rep. (2003) 10.1039/b208815k

[15]

Henrich "Matching the power of high throughput screening to the chemical diversity of natural products" Nat. Prod. Rep. (2013) 10.1039/c3np70052f

[16]

Lautie "Unraveling plant natural chemical diversity for drug discovery purposes" Front. Pharmacol. (2020) 10.3389/fphar.2020.00397

[17]

Harvey "The re-emergence of natural products for drug discovery in the genomics era" Nat. Rev. Drug Discov. (2015) 10.1038/nrd4510

[18]

Corcoran "LC–NMR–MS in drug discovery" Drug Discov. Today (2003) 10.1016/s1359-6446(03)02749-1

[19]

Gifted microbes for genome mining and natural product discovery

Richard H Baltz

Journal of Industrial Microbiology and Biotechnolo... 2017 10.1007/s10295-016-1815-x

[20]

Synthesis and Antiviral Activities of Neoechinulin B and Its Derivatives

Kota Nishiuchi, Hirofumi Ohashi, Kazane Nishioka et al.

Journal of Natural Products 2021 10.1021/acs.jnatprod.1c01120

[21]

Cullen "Human immunodeficiency virus as a prototypic complex retrovirus" J. Virol. (1991) 10.1128/jvi.65.3.1053-1056.1991

[22]

Foley "Roles for CXC chemokine ligands 10 and 11 in recruiting CD4+ T cells to HIV-1-infected monocyte-derived macrophages, dendritic cells, and lymph nodes" J. Immunol. (2005) 10.4049/jimmunol.174.8.4892

[23]

Montarroyos, U.R., Miranda-Filho, D.B., César, C.C., Souza, W.V., Lacerda, H.R., de Fátima Pessoa Militão Albuquerque, M., Aguiar, M.F., and de Alencar Ximenes, R.A. (2014). Factors related to changes in CD4+ T-cell counts over time in patients living with HIV/AIDS: A multilevel analysis. PLoS ONE, 9. 10.1371/journal.pone.0084276

[24]

UNAIDS (2022, February 01). 38 million people are living with HIV around the world. Available online: https://www.unaids.org/en/resources/infographics/people-living-with-hiv-around-the-world.

[25]

Zhang "Alachalasins A–G, new cytochalasins from the fungus Stachybotrys charatum" Bioorg. Med. Chem. (2008) 10.1016/j.bmc.2007.11.042

[26]

Zhang "Corrigendum to "Alachalasins A–G, new cytochalasins from the fungus Stachybotrys charatum"" Bioorg. Med. Chem. (2009) 10.1016/j.bmc.2007.11.084

[27]

Liu "Isoprenylated chromone derivatives from the plant endophytic fungus Pestalotiopsis fici" J. Nat. Prod. (2009) 10.1021/np900308s

[28]

Liu "Pestalofones A–E, bioactive cyclohexanone derivatives from the plant endophytic fungus Pestalotiopsis fici" Bioorg. Med. Chem. (2009) 10.1016/j.bmc.2008.11.066

[29]

Guo "Diketopiperazines from the Cordyceps-colonizing fungus Epicoccum nigrum" J. Nat. Prod. (2009) 10.1021/np900654a

[30]

Zou "Two New Imidazolone-Containing Alkaloids and Further Metabolites from the Ascomycete Fungus Tricladium sp." Chem. Biodivers. (2011) 10.1002/cbdv.201000372

[31]

Chen "Armochaetoglobins K–R, Anti-HIV Pyrrole-Based Cytochalasans from Chaetomium globosum TW1-1" Eur. J. Org. Chem. (2015) 10.1002/ejoc.201403678

[32]

Ma "Phenylspirodrimanes with anti-HIV activity from the sponge-derived fungus Stachybotrys chartarum MXH-X73" J. Nat. Prod. (2013) 10.1021/np400683h

[33]

Zhao "Stachybotrysams A–E, prenylated isoindolinone derivatives with anti-HIV activity from the fungus Stachybotrys chartarum" Phytochem. Lett. (2017) 10.1016/j.phytol.2017.04.031

[34]

Li "Isoindolinone-type alkaloids from the sponge-derived fungus Stachybotrys chartarum" Tetrahedron (2014) 10.1016/j.tet.2014.07.047

[35]

Zhou "Aspernigrins with anti-HIV-1 activities from the marine-derived fungus Aspergillus niger SCSIO Jcsw6F30" Bioorg. Med. Chem. Lett. (2016) 10.1016/j.bmcl.2015.12.005

[36]

Niu "Eutypellazines A–M, thiodiketopiperazine-type alkaloids from deep sea derived fungus Eutypella sp. MCCC 3A00281" RSC Adv. (2017) 10.1039/c7ra05774a

[37]

Zhao "Truncateols OV, further isoprenylated cyclohexanols from the sponge-associated fungus Truncatella angustata with antiviral activities" Phytochemistry (2018) 10.1016/j.phytochem.2018.07.017

[38]

Tan "Penicillixanthone A, a marine-derived dual-coreceptor antagonist as anti-HIV-1 agent" Nat. Prod. Res. (2019) 10.1080/14786419.2017.1416376

[39]

Hu "Anti-HIV Compounds from the Deep-Sea-Derived Fungus Chaetomium globosum" Chem. Biodivers. (2022) 10.1002/cbdv.202100804

[40]

Yang "Phomonaphthalenone A: A novel dihydronaphthalenone with anti-HIV activity from Phomopsis sp. HCCB04730" Phytochem. Lett. (2013) 10.1016/j.phytol.2013.02.003

[41]

Altertoxins with potent anti-HIV activity from Alternaria tenuissima QUE1Se, a fungal endophyte of Quercus emoryi

Bharat P. Bashyal, Brian P. Wellensiek, Rajesh Ramakrishnan et al.

Bioorganic & Medicinal Chemistry 2014 10.1016/j.bmc.2014.08.039

[42]

Ding, J., Zhao, J., Yang, Z., Ma, L., Mi, Z., Wu, Y., Guo, J., Zhou, J., Li, X., and Guo, Y.J.V. (2017). Microbial natural product alternariol 5-O-methyl ether inhibits HIV-1 integration by blocking nuclear import of the pre-integration complex. Viruses, 9. 10.3390/v9050105

[43]

Zhao "Bioactive steroids and sorbicillinoids isolated from the endophytic fungus Trichoderma sp. Xy24" J. Asian. Nat. Prod. Res. (2017) 10.1080/10286020.2017.1285908

[44]

Yang "New azaphilones, phomopsones AC with biological activities from an endophytic fungus Phomopsis sp. CGMCC No. 5416" Fitoterapia (2020) 10.1016/j.fitote.2020.104573

[45]

Liu "Three new compounds from endophytic fungus Periconia sp. F-31" Chin. Pharm. Sci. (2020) 10.5246/jcps.2020.04.023

[46]

Pang "Metabolites from the plant endophytic fungus Aspergillus sp. CPCC 400735 and their anti-HIV activities" J. Nat. Prod. (2017) 10.1021/acs.jnatprod.6b00878

[47]

Lianeras "Etiologies and features of acute viral hepatitis in Spain" Clin. Gastroenterol. Hepatol. (2021) 10.1016/j.cgh.2020.07.006

[48]

Frediansyah "Acute severe hepatitis of unknown etiology in children: A mini-review" Narra J. (2022) 10.52225/narra.v2i2.83

[49]

Bandiera "Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma" Curr. Opin. Virol. (2016) 10.1016/j.coviro.2016.09.010

[50]

Seto "Acute-on-chronic liver failure in chronic hepatitis B" J. Gastroenterol. Hepatol. (2012) 10.1111/j.1440-1746.2011.06971.x

Showing 50 of 202 references

Metrics

30

Citations

202

References

Details

Published: Jul 05, 2022
Vol/Issue: 27(13)
Pages: 4305
License: View

Authors

A

Andri Frediansyah

PRTPP, National Research and Innovation Agency (BRIN), Yogyakarta 55861, Indonesia

F

Fajar Sofyantoro

Faculty of Biology, Gadjah Mada University, Yogyakarta 55281, Indonesia

S

Saad Alhumaid

Administration of Pharmaceutical Care, Al-Ahsa Health Cluster, Ministry of Health, Al-Ahsa 31982, Saudi Arabia

A

Abbas Al Mutair

Research Center, Almoosa Specialist Hospital, Al-Ahsa 36342, Saudi Arabia; College of Nursing, Princess Norah Bint Abdulrahman University, Riyadh 11564, Saudi Arabia; School of Nursing, Wollongong University, Wollongong, NSW 2522, Australia; Nursing Department, Prince Sultan Military College of Health Sciences, Dhahran 33048, Saudi Arabia

H

Hawra AlBayat

Infectious Disease Department, King Saud Medical City, Riyadh 7790, Saudi Arabia

H

Hayyan I. Altaweil

Department of Clinical Laboratory Sciences, Mohammed Al-Mana College of Health Sciences, Dammam 34222, Saudi Arabia

H

Hani M. Al-Afghani

Laboratory Department, Security Forces Hospital, Makkah 24269, Saudi Arabia; Gene Center for Research and Training, Jeddah 2022, Saudi Arabia

A

Abdullah A. AlRamadhan

Laboratory and Toxicology Department, Security Forces Specialized Comprehensive Clinics, Al-Ahsa 36441, Saudi Arabia

M

Mariam R. AlGhazal

Hematopathology Department, Dammam Regional Laboratory, Dammam 1854, Saudi Arabia

S

Safaa A. Turkistani

Fakeeh College for Medical Sciences, Jeddah 21134, Saudi Arabia

A

Abdulmonem A. Abuzaid

Medical Microbiology Department, Security Forces Hospital Programme, Dammam 32314, Saudi Arabia

A

Ali A. Rabaan

Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran 31311, Saudi Arabia; College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia; Department of Public Health and Nutrition, Faculty of Basic and Applied Sciences, University of Haripur, Haripur 22610, Pakistan

Cite This Article

Andri Frediansyah, Fajar Sofyantoro, Saad Alhumaid, et al. (2022). Microbial Natural Products with Antiviral Activities, Including Anti-SARS-CoV-2: A Review. Molecules, 27(13), 4305. https://doi.org/10.3390/molecules27134305

Microbial Natural Products with Antiviral Activities, Including Anti-SARS-CoV-2: A Review

You May Also Like